GENELUX CORPORATION

GNLX73

High Growth

$2.55arrow_drop_up4.47%$0.10

High Growth

Penny Stock

GNLX73

$2.55

arrow_drop_up4.47%$0.10

High Growth

Penny Stock

Performance History

Key Stats
Open	$2.53
Prev. Close	$2.46
EPS	-0.94
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$88.07M
PE Ratio	-

	LOW	HIGH
Day Range	2.42	2.56
52 Week Range	1.60	25.23

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-0.94

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About GENELUX CORPORATION (GNLX)

GENELUX CORPORATION (GNLX) is a biotechnology company that focuses on developing and commercializing innovative gene-based immunotherapeutic products for the treatment of cancer and other diseases. The company's lead product candidate is GL-ONC1, a modified herpes simplex virus type 1 (HSV-1) that selectively replicates in and kills cancer cells. GL-ONC1 has shown promising results in preclinical and early-stage clinical trials, demonstrating its potential as a safe and effective cancer treatment.

In addition to GL-ONC1, GENELUX is also developing other gene-based immunotherapies, including GL-ONC2 and GL-ONC3, which target different types of cancer. These product candidates are designed to harness the power of the immune system to selectively target and destroy cancer cells, while sparing healthy cells. The company's innovative approach to cancer treatment has garnered significant attention from the medical and scientific communities, and GENELUX is actively collaborating with leading research institutions to further advance its product pipeline.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. Thomas Zindrick J.D.
Headquarters: Westlake Village
Employees: 20
Exchange: NASDAQ

Keep an eye on GENELUX CORPORATION

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is GENELUX CORPORATION's (GNLX) price per share?

The current price per share for GENELUX CORPORATION (GNLX) is $2.55. The stock has seen a price change of $0.11 recently, indicating a 4.47% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for GENELUX CORPORATION (GNLX)?

For GENELUX CORPORATION (GNLX), the 52-week high is $25.23, which is 889.41% from the current price. The 52-week low is $1.6, the current price is 59.37% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is GENELUX CORPORATION (GNLX) a growth stock?

GENELUX CORPORATION (GNLX) has shown an average price growth of -4.13% over the past three years. It has received a score of 100 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying GENELUX CORPORATION as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is GENELUX CORPORATION (GNLX) stock price performance year to date (YTD)?

As of the latest data, GENELUX CORPORATION (GNLX) has a year-to-date price change of -82.83%. Over the past month, the stock has experienced a price change of -1.92%. Over the last three months, the change has been 15.91%. Over the past six months, the figure is -47.53%.

help

Is GENELUX CORPORATION (GNLX) a profitable company?

GENELUX CORPORATION (GNLX) has a net income of -$28.3M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -341.44K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$24.16M. Furthermore, the EBITDA is -$26.96M.

help

What is the market capitalization of GENELUX CORPORATION (GNLX)?

GENELUX CORPORATION (GNLX) has a market capitalization of $88.07M. The average daily trading volume is 2.48, indicating the stock's liquidity and investor engagement.